MRNX
Defiance Daily Target 2X Long MRNA ETF
MRNX
Closed
$81.30
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
MRNX was created on 2026-02-03 by Defiance. The fund's investment portfolio concentrates primarily on health care equity. MRNX seeks to deliver 2x leveraged exposure to the daily share price movement of Moderna, Inc. (NASDAQ: MRNA), net fees and expenses, through derivatives like swap agreements. MRNA develops mRNA-based vaccines and therapies, best known for its COVID-19 vaccine.
Company
Defiance
Asset class
Equity
Inception date
2026
Investment segment
Health Care
ISIN
US88636X8157
Website
Key stats
Open
$82.40
Volume
174.50K
AUM
$22.87M
Prev. close
$84.72
Expense ratio
1.34%
P/E
0.00
$78.31
Day’s Range
$86.50
$14.95
52W Range
$143.84
What’s in the fund
12
Total holdings
United States Treasury Bills 0%
46.49%
MODERNA INC SWAP CS-L
36.71%
MODERNA INC SWAP CF-L
35.15%
MODERNA INC.-SWAP-JNST-L
34.51%
MODERNA INC.-SWAP-NBCB-L
34.19%
MODERNA INC SWAP MAREX-L
33.48%
MODERNA INC SWAP NOMURA-L
32.95%
First American Government Obligs X
9.70%
US DOLLARS
7.38%
Others
-170.56%
Returns
Performance
_
Difference
_
Defiance Daily Target 2X Long MRNA ETF
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply